AstraZeneca’s Trixeo has been approved in the EU as a [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

The European Medicines Agency (EMA) has accepted Almirall’s application to [...]

SERB has completed its €115 million licensing agreement with Hansa [...]

BridgeBio has published results from its pivotal Phase 3 Propel [...]

The Pistoia Alliance has announced the next phase of its [...]